Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Rieber, Nikolaus ^a,b   Graf, Anna ^a   Hartl, Dominik ^a,b   Urschel, Simon ^a   Belohradsky, Bernd H ^a   Liese, Johannes ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DPT IMPFSTOFF; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; IPV MERIEUX; PERTUSSIS TOXIN; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACELLULAR VACCINE; CYTOKINE; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ARTICLE; BORDETELLA PERTUSSIS; CD8+ CD9+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MULTICENTER STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; CLINICAL TRIAL; DEMOGRAPHY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; VACCINATION;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOKINES; DEMOGRAPHY; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MALE; PERTUSSIS VACCINE; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 79952425208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017271     Document Type: Article

References (28)

1. (2005) Pertussis vaccines-WHO position paper. Wkly Epidemiol Rec 80: 31-39.
2. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, et al. (1995) Household contact study of Bordetella pertussis infections. Clin Infect Dis 21: 1211-1219.
3. von Konig CH, Halperin S, Riffelmann M, Guiso N, (2002) Pertussis of adults and infants. Lancet Infect Dis 2: 744-750.
4. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, et al. (2007) Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 26: 293-299.
5. Edwards KMD, Michael D, (2008) Pertussis Vaccine. In: Plotkin Stanely A, Orenstein Walter A, Offit Paul A, editors. Vaccines, 5th Edition Philadelphia WB Saunders Company pp. 467-517.
6. Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, et al. (1998) Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93: 1-10.
7. Esposito S, Agliardi T, Giammanco A, Faldella G, Cascio A, et al. (2001) Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun 69: 4516-4520.
8. Vermeulen F, Verscheure V, Damis E, Vermeylen D, Leloux G, et al. (2010) Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines. Clin Vaccine Immunol 17: 258-262.
9. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A, (1997) Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 65: 2168-2174.
10. Ausiello CM, Lande R, Urbani F, la Sala A, Stefanelli P, et al. (1999) Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun 67: 4064-4071.
11. Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, et al. (2008) Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 26: 6929-6935.
12. Liese JG, Rieber N, Malzer T, Ocak M, Johnson DR, et al. (7 July 2010, posting date) Reactogenicity of Tetanus, Diphtheria, 5-Component Acellular Pertussis Vaccine Administered as a Sixth Consecutive Acellular Pertussis Vaccine Dose to Adolescents. Pediatr Infect Dis J doi:10.1097/INF.1090b1013e3181ea5866.
13. Liese JG, Meschievitz CK, Harzer E, Froeschle J, Hosbach P, et al. (1997) Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J 16: 1038-1044.
14. Liese JG, Stojanov S, Zink TH, Froeschle J, Klepadlo R, et al. (2001) Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 20: 981-988.
15. Rowe J, Yerkovich ST, Richmond P, Suriyaarachchi D, Fisher E, et al. (2005) Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun 73: 8130-8135.
16. Zorzeto TQ, Higashi HG, da Silva MT, Carniel Ede F, Dias WO, et al. (2009) Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants. Clin Vaccine Immunol 16: 544-550.
17. Pihlgren M, Dubois PM, Tomkowiak M, Sjogren T, Marvel J, (1996) Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 184: 2141-2151.
18. Neal ZC, Splitter GA, (1998) Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies. J Virol 72: 8052-8060.
19. Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H, (1999) Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol 29: 284-290.
20. Pihlgren M, Arpin C, Walzer T, Tomkowiak M, Thomas A, et al. (1999) Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. Int Immunol 11: 699-706.
21. Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, et al. (2003) Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis 188: 40-52.
22. Dikopoulos N, Jomantaite I, Schirmbeck R, Reimann J, (2003) Specific, functional effector/memory CD8+ T cells are found in the liver post-vaccination. J Hepatol 39: 910-917.
23. Robinson HL, Amara RR, (2005) T cell vaccines for microbial infections. Nat Med 11: S25-32.
24. Saukkonen K, Cabellos C, Burroughs M, Prasad S, Tuomanen E, (1991) Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med 173: 1143-1149.
25. Mills KHG, (2001) Immunity to Bordetella Pertussis. Microbes and Infection pp. 655-677.
26. Feunou PF, Bertout J, Locht C, (2010) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One 5: e10178.
27. Meyer CU, Zepp F, Decker M, Lee M, Chang SJ, et al. (2007) Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin Vaccine Immunol 14: 288-292.
28. Yano A, Komatsu T, Ishibashi M, Udaka K, (2007) Potent CTL induction by a whole cell pertussis vaccine in anti-tumor peptide immunotherapy. Microbiol Immunol 51: 685-699.